Neuropathological heterogeneity in Alzheimer's disease: A study of 80 cases using principal components analysis

Neuropathology

Volumn 20, Issue 1, 2000, Pages 31-37

  Armstrong, Richard A ^a   Nochlin, David ^b   Bird, Thomas D ^c  

^a ASTON UNIVERSITY   (United Kingdom)

^b Health Sciences Center   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Analysis; Apolipoprotein E; Neurodegeneration; Neurofibrillary tangles; Principal components; Senile plaques

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CINGULATE GYRUS; DISEASE COURSE; DISEASE SEVERITY; FRONTAL LOBE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OCCIPITAL LOBE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SENILE PLAQUE; SUBICULUM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; GENETIC HETEROGENEITY; GENOTYPE; HUMANS; MIDDLE AGED; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; SENILE PLAQUES;

EID: 0034111406     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2000.00284.x     Document Type: Article

References (34)

1. Armstrong RA, Myers D. Principal components analysis of Alzheimer's disease based on neuropathological data: A study of 79 patients. Neurosci Res Communs 1992; 11: 1-9.
2. Armstrong RA, Wood L. The identification of pathological subtypes of Alzheimer's disease using cluster analysis. Acta Neuropathol 1994; 88: 60-66.
3. Forstl H, Fischer P. Diagnostic confirmation, severity and subtypes of Alzheimer's disease. Eur Arch Psy Clin Neurosci 1994; 244: 252-260.
4. Vermersch P, Frigand B, Delacourte A. Mapping of neurofibrillary degeneration in Alzheimer's disease: Evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol 1992; 85: 48-54.
5. Ritchie K, Touchon J. Heterogeneity in senile dementia of the Alzheimer type: Individual differences, progressive deterioration or clinical subtypes? J Clin Epidemiol 1992; 45: 1391-1398.
6. Goate R, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (London) 1991; 349: 704-706.
7. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1992; 261: 921-923.
8. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 1993; 375: 754-760.
9. Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-977.
10. Strittmatter WJ, Weisgraber KH, Huang DY et al. Binding of human apolipoprotein E to synthetic amyloid-β-peptide: isoform specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 8098-8102.
11. Berr C, Hauw JJ, Delaere P et al. Apolipoprotein E allele ε4 is linked to increased deposition of the amyloid β-peptide (Aβ) in cases with or without Alzheimer's disease. Neurosci Lett 1994; 178: 221-224.
12. Gearing M, Schneider JA, Robins RS et al. Regional variation in the distribution of apolipoprotein E and Aβ in Alzheimer's disease. J Neuropathol Exp Neurol 1995; 54: 833-841.
13. Hyman BT, West HL, Rebeck GW et al. Quantitative analysis of senile plaques in Alzheimer's disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down's syndrome). Proc Natl Acad Sci USA 1995; 92: 3586-3590.
14. Beffert U, Poirier J. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann NY Acad Sci 1996; 777: 166-174.
15. Polvikoski T, Sulkava R, Hatha M et al. Apolipoprotein E, dementia and cortical deposition of β-amyloid protein. New Engl J Med 1995; 333: 1242-1247.
16. Richey PL, Siedlak SL, Smith MA, Perry G. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer's disease: Implications for disease pathogenesis. Biochem Biophys Res Commun 1995; 208: 657-663.
17. Nagy Z, Esiri MM, Jobst KA et al. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neurosci 1995; 69: 757-761.
18. Boller F. Alzheimer's disease and Parkinson's disease: clinical and pathological associations. In: Reisberg B (ed.) Alzheimer's Disease. The Standard Reference. London: MacMillan, 1983; 295-302.
19. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol 1986; 19: 253-262.
20. Pearson RCA, Esiri MM, Hiorns RW et al. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci USA 1985; 82: 4531-4534.
21. Braak H, Braak E. The human entorhinal cortex: Normal morphology and lamina-specific pathology in various diseases. Neurosci Res 1992; 15: 6-31.
22. Armstrong RA, Myers D, Smith CUM. Alzheimer's disease: Size class frequency distributions of senile plaques: Do they indicate when a brain tissue was affected? Neurosci Lett 1991; 127: 223-226.
23. De Lacoste M, White CL III. The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system. Neurobiol Aging 1993; 14: 1-16.
24. Vogt BA, Van Hoesen GW, Vogt LJ. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease. Acta Neuropathol 1990; 80: 581-589.
25. Mann UM, Mohr E, Gearing M, Chase TM. Heterogeneity in Alzheimer's disease: Progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. J Neurol Neurosurg Psychiatr 1992; 55: 956-959.
26. Mirra SS, Heyman A, McKeel D et al. The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurol 1991; 41: 479-486.
27. Pielou EC. An Introduction to Mathematical Ecology. New York: J.Wiley, 1969.
28. Armstrong RA. Relationships between morphological types of plaque in Alzheimer's disease as revealed in silver and immunostained preparations. Neurodegen 1993; 2: 259-266.
29. Haupt M, Kurz A, Pollman S, Romero B. Alzheimer's disease: Identical phenotype of familial and non-familial cases. J Neurol 1992; 239: 248-250.
30. Nochlin D, Van belle G, Bird TD, Sumi SM. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease. Alz Dis Assoc Dis 1993; 7: 212-222.
31. Chui HC, Teng EL, Henderson VW, Moy AC. Clinical subtypes of dementia of the Alzheimer type. Neurol 1985; 35: 1544-1550.
32. Gomez-Isla T, West HL, Rebeck GW et al. Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Anns Neurol 1996; 39: 62-70.
33. Oyama F, Shimada H, Oyama R, Ihara Y. Apolipoprotein E genotype, Alzheimer pathologies and related gene expression in the aged population. Mole Brain Res 1995; 29: 92-98.
34. Lehtovirta M, Soininen H, Laakso MP et al. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon-4 allele. J Neurol Neurosurg Psychiatr 1996; 60: 644-649.